![Katja Buhrer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katja Buhrer
Keine laufenden Positionen mehr
Profil
Katja Buhrer worked as a Managing Director at MBS Value Partners, Inc. from 2011 to 2017.
She then served as the COO & VP-Corporate Development & Investor Relations at Kindred Biosciences, Inc. from 2018 to 2021.
In 2022, she became the Chief Strategy Officer at ObsEva SA. Prior to her professional career, Ms. Buhrer completed her undergraduate degree at The University of New South Wales.
Ehemalige bekannte Positionen von Katja Buhrer
| Unternehmen | Position | Ende |
|---|---|---|
| OBSEVA SA | Investor Relations Kontakt | 02.02.2022 |
| KINDRED BIOSCIENCES, INC. | Geschäftsführer | 01.12.2021 |
MBS Value Partners, Inc.
 MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Corporate Officer/Principal | 01.11.2017 |
Ausbildung von Katja Buhrer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBS Value Partners, Inc.
MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Finance |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
